ArticlePLoS pathogens2026
Novel duck reovirus σC hijacks the mitochondrial COQ6-CoQ10 axis to drive NLRP3-dependent pyroptosis.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Mitochondrial metabolic homeostasis serves as a critical checkpoint that integrates cellular bioenergetics with innate immunity. While viruses often subvert mitochondrial functions to manipulate cell fate, the specific viral determinants that directly reprogram host metabolic enzymes to drive inflammatory injury remain incompletely defined. Here, using infection with a highly virulent novel duck reovirus (NDRV) strain as a model of systemic immunopathology, we identify the viral capsid protein σC as a metabolic virulence factor. We show that σC binds to the mitochondrial targeting sequence (MTS) of COQ6, a conserved monooxygenase required for coenzyme Q10 (CoQ10) biosynthesis, and blocks its mitochondrial import, thereby disrupting CoQ10 homeostasis. This metabolic blockade induces mitochondrial dysfunction, characterized by mtROS accumulation and the cytosolic release of oxidized mitochondrial DNA (ox-mtDNA). We demonstrate that ox-mtDNA acts as a danger signal that triggers NLRP3 activation and downstream gasdermin E (GSDME)-dependent pyroptosis. Moreover, σC knockdown in infected cells reduces ox-mtDNA release and attenuates pyroptosis. CoQ10 supplementation restores mitochondrial homeostasis and alleviates NDRV-induced inflammatory pathology in vitro and in vivo without detectably reducing viral RNA loads, consistent with a host-directed disease tolerance mechanism. Collectively, these findings define a σC-COQ6-CoQ10-ox-mtDNA-NLRP3 axis that links a structural avian orthoreovirus protein to metabolic reprogramming and highlight the COQ6-CoQ10 pathway as a tractable therapeutic target for limiting virus-induced inflammatory tissue damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.